CODEINE 15 15 MG
CODEINE PHOSPHATE : 15 MG · DIN 02009889 · LABORATOIRE RIVA INC.
Health Canada status: DORMANT
What is CODEINE 15?
CODEINE 15 15 MG contains CODEINE PHOSPHATE : 15 MG. It is listed in the Health Canada Drug Product Database under DIN 02009889, held by LABORATOIRE RIVA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 05-Nov-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02009889 |
|---|---|
| Brand name | CODEINE 15 |
| Generic / active ingredient | CODEINE PHOSPHATE : 15 MG |
| Manufacturer | LABORATOIRE RIVA INC. |
| Strength | 15 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | R05DA04 CODEINE |
| AHFS class | 28:08.08 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 05-Nov-2021 |
| Original market date | 1994-12-31 00:00:00 |
Is CODEINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by PURDUE PHARMA, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code R05DA04 CODEINE. 9 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CODEINE 30 | 30 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED | DIN 02009757 |
| CODEINE CONTIN 100MG CONTROLLED RELEASE TAB | 100 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED | DIN 02163748 |
| CODEINE CONTIN 150MG CONTROLLED RELEASE TAB | 150 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED | DIN 02163780 |
| CODEINE CONTIN 200MG CONTROLLED RELEASE TAB | 200 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED | DIN 02163799 |
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB | 50 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED | DIN 02230302 |
| CODEINE PHOSPHATE SYRUP | 25 MG / 5 ML | SYRUP | LABORATOIRE ATLAS INC | MARKETED | DIN 00050024 |
| LINCTUS CODEINE BLANC | 10 MG / 5 ML | SOLUTION | LABORATOIRE ATLAS INC | MARKETED | DIN 00380571 |
| TEVA-CODEINE | 15 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00593435 |
| TEVA-CODEINE | 30 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00593451 |
| CODEINE PHOSPHATE INJ 30MG/ML | 30 MG / 1 ML | SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00497282 |
Who else supplies CODEINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CODEINE appears in 25 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.